Postnatal Consequences of Fetal Inflammation

胎儿炎症的产后后果

基本信息

  • 批准号:
    7111958
  • 负责人:
  • 金额:
    $ 17.51万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-08-01 至 2008-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): In response to the RFA "Innovative Grants on Immune Tolerance," we propose to test the hypothesis that antenatal exposure to inflammation induces innate immune responses via the fetal lungs that will reprogram postnatal airway responsiveness and immune status. The majority of very low birth weight preterm infants are exposed to chronic indolent chorioamnionitis (inflammation) that can alter lung development and result in bronchopulmonary dysplasia. Many near-term and term infants also are exposed to antenatal infection. We have developed chronic chorioamnionitis models in fetal sheep using intraamniotic injections of endotoxin or live Ureaplasma, the organism most frequently associated with preterm delivery. Fetal sheep exposed to endotoxin develop innate immune paralysis of lung and systemic monocytes as well as other indicators of immune modulation. We will cause chronic chorioamnionitis and lung inflammation in fetal sheep using endotoxin or Ureaplasma parvum. We will evaluate monocyte and lymphocyte responses in the fetus at term in groups of animals. We will randomize other groups of animals to spontaneous delivery and sensitization with house dust mite antigen as newborns. We will then evaluate airway reactivity and immune status at 8 wks of age. The evaluations will include characterization and responses to stimulation in vitro of lymphocytes and monocytes from the blood, lung tissue, caudal mediastinal lymph nodes, spleen and thymus. The experiments will directly test the effects of two clinically relevant fetal exposures on postnatal lung sensitization and function. Relevance to public health: Many preterm and term human fetuses are exposed to chorioamnionitis/ inflammation which can cause profound immune modulation in animal models. Preterms have an increased risk of developing asthma/airway reactivity and the incidence of asthma is increasing in children. This research will use clinically relevant prenatal exposures and postnatal sensitization to establish under controlled conditions any link between antenatal inflammation and the hygiene hypothesis.
描述(由申请人提供):为了响应RFA“免疫耐受创新赠款”,我们建议检验以下假设:产前暴露于炎症通过胎肺诱导先天性免疫应答,这将重新编程出生后气道反应性和免疫状态。大多数极低出生体重早产儿暴露于慢性惰性绒毛膜炎(炎症),可改变肺发育并导致支气管肺发育不良。许多新生儿和足月儿也有产前感染的风险。我们已经开发了慢性绒毛膜炎模型的羊胎儿羊膜腔内注射内毒素或活脲原体,有机体最常见的早产。暴露于内毒素的胎羊发生肺和全身单核细胞的先天性免疫麻痹以及其他免疫调节指标。我们将使用内毒素或脲原体引起胎羊慢性绒毛膜炎和肺部炎症。我们将在动物组中评价足月胎儿的单核细胞和淋巴细胞反应。我们将随机分配其他组动物进行自然分娩,并将屋尘螨抗原致敏作为新生动物。然后我们将评估8周龄时的气道反应性和免疫状态。评价将包括来自血液、肺组织、尾纵隔淋巴结、脾脏和胸腺的淋巴细胞和单核细胞的体外刺激表征和反应。实验将直接测试两种临床相关的胎儿暴露对出生后肺致敏和功能的影响。与公共卫生的相关性:许多早产和足月人类胎儿暴露于绒毛膜炎/炎症,其可在动物模型中引起深刻的免疫调节。早产儿发生哮喘/气道反应性的风险增加,儿童哮喘的发病率也在增加。这项研究将使用临床相关的产前暴露和产后致敏,在受控条件下建立产前炎症和卫生假说之间的任何联系。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ALAN H JOBE其他文献

ALAN H JOBE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ALAN H JOBE', 18)}}的其他基金

Initiation and Progression of Preterm Lung Injury with Ventilation
通气引起早产肺损伤的发生和进展
  • 批准号:
    8333719
  • 财政年份:
    2012
  • 资助金额:
    $ 17.51万
  • 项目类别:
Initiation and Progression of Preterm Lung Injury with Ventilation
通气引起早产肺损伤的发生和进展
  • 批准号:
    8675892
  • 财政年份:
    2012
  • 资助金额:
    $ 17.51万
  • 项目类别:
Initiation and Progression of Preterm Lung Injury with Ventilation
通气引起早产肺损伤的发生和进展
  • 批准号:
    9060755
  • 财政年份:
    2012
  • 资助金额:
    $ 17.51万
  • 项目类别:
Initiation and Progression of Preterm Lung Injury with Ventilation
通气引起早产肺损伤的发生和进展
  • 批准号:
    8517784
  • 财政年份:
    2012
  • 资助金额:
    $ 17.51万
  • 项目类别:
Late Preterm Birth, Ureaplasma Species and Childhood Lung Disease
晚期早产、解脲支原体和儿童肺病
  • 批准号:
    7713829
  • 财政年份:
    2009
  • 资助金额:
    $ 17.51万
  • 项目类别:
Late Preterm Birth, Ureaplasma Species and Childhood Lung Disease
晚期早产、解脲支原体和儿童肺病
  • 批准号:
    7938669
  • 财政年份:
    2009
  • 资助金额:
    $ 17.51万
  • 项目类别:
Late Preterm Birth, Ureaplasma Species and Childhood Lung Disease
晚期早产、解脲支原体和儿童肺病
  • 批准号:
    8304364
  • 财政年份:
    2009
  • 资助金额:
    $ 17.51万
  • 项目类别:
Late Preterm Birth, Ureaplasma Species and Childhood Lung Disease
晚期早产、解脲支原体和儿童肺病
  • 批准号:
    8112493
  • 财政年份:
    2009
  • 资助金额:
    $ 17.51万
  • 项目类别:
Postnatal Consequences of Fetal Inflammation
胎儿炎症的产后后果
  • 批准号:
    7268104
  • 财政年份:
    2006
  • 资助金额:
    $ 17.51万
  • 项目类别:
ALVEOLAR HOMEOSTASIS OF SURFACTANT LIPIDS AND PROTEINS
表面活性剂脂质和蛋白质的肺泡稳态
  • 批准号:
    6606075
  • 财政年份:
    2002
  • 资助金额:
    $ 17.51万
  • 项目类别:

相似国自然基金

Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
  • 批准号:
    30801055
  • 批准年份:
    2008
  • 资助金额:
    19.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Mucosal immunity to sapovirus in early childhood
幼儿期对沙波病毒的粘膜免疫
  • 批准号:
    10677051
  • 财政年份:
    2023
  • 资助金额:
    $ 17.51万
  • 项目类别:
Gastroenteritis virus infections in South African children: secretor status-linkedsusceptibility, prevalence and genetic diversity and humoral responses to norovirusinfection
南非儿童胃肠炎病毒感染:分泌者状态相关的易感性、患病率和遗传多样性以及对诺如病毒感染的体液反应
  • 批准号:
    10666007
  • 财政年份:
    2023
  • 资助金额:
    $ 17.51万
  • 项目类别:
ADEPT-STAR therapy for high risk neuroblastoma
ADEPT-STAR 治疗高危神经母细胞瘤
  • 批准号:
    10760738
  • 财政年份:
    2023
  • 资助金额:
    $ 17.51万
  • 项目类别:
Infant Immunologic and Neurologic Development following Maternal Infection in Pregnancy during Recent Epidemics
近期流行病期间妊娠期感染后婴儿的免疫和神经系统发育
  • 批准号:
    10784250
  • 财政年份:
    2023
  • 资助金额:
    $ 17.51万
  • 项目类别:
Aire-dependent thymic B-1a cells play a key role in neonatal tolerance induction
Aire 依赖性胸腺 B-1a 细胞在新生儿耐受诱导中发挥关键作用
  • 批准号:
    10660882
  • 财政年份:
    2023
  • 资助金额:
    $ 17.51万
  • 项目类别:
Elucidating and harnessing the molecular mechanisms of protective clearance in endogenous and engineered phagocytes
阐明和利用内源性和工程化吞噬细胞保护性清除的分子机制
  • 批准号:
    10729935
  • 财政年份:
    2023
  • 资助金额:
    $ 17.51万
  • 项目类别:
Role of meningeal lymphatic vasculature in neuroimmune communication development
脑膜淋巴管系统在神经免疫通讯发育中的作用
  • 批准号:
    10566682
  • 财政年份:
    2023
  • 资助金额:
    $ 17.51万
  • 项目类别:
The Role of CD4+ Memory T cell Subtypes in Periodontal Disease Recurrence
CD4 记忆 T 细胞亚型在牙周病复发中的作用
  • 批准号:
    10642981
  • 财政年份:
    2023
  • 资助金额:
    $ 17.51万
  • 项目类别:
Leveraging early-life microbes to prevent type 1 diabetes
利用生命早期微生物预防 1 型糖尿病
  • 批准号:
    10659611
  • 财政年份:
    2023
  • 资助金额:
    $ 17.51万
  • 项目类别:
Interplay of the T Cell Repertoire Development and Early Life Exposure on Incident Risk of Peanut Allergy
T 细胞库发育和生命早期接触对花生过敏事件风险的相互作用
  • 批准号:
    10742029
  • 财政年份:
    2023
  • 资助金额:
    $ 17.51万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了